Orange Book product · Generic (ANDA)
ISOPROTERENOL HYDROCHLORIDE
ISOPROTERENOL HYDROCHLORIDE
At a glance
May 19, 2021
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 19, 2021
5 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
ISOPROTERENOL HYDROCHLORIDE
Strength
0.2MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 211237
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ISOPROTERENOL HYDROCHLORIDE
- —ISOPROTERENOL HYDROCHLORIDEBrand (NDA)
NDA 010375 · 3M
- —ISUPRELBrand (NDA)
NDA 011178 · SANOFI AVENTIS US
- —NORISODRINE AEROTROLBrand (NDA)
NDA 016814 · ABBOTT
- —ISUPRELBrand (NDA)
NDA 010515 · BAUSCH
- —AEROLONEBrand (NDA)
NDA 007245 · LILLY
- —ISUPRELBrand (NDA)
NDA 006327 · SANOFI AVENTIS US
- —VAPO-ISOBrand (NDA)
NDA 016813 · FISONS
- —ISUPRELBrand (NDA)
NDA 006328 · SANOFI AVENTIS US
- 2026ISOPROTERENOL HYDROCHLORIDEGeneric (ANDA)
ANDA 220299 · ASPIRO
- 2025ISOPROTERENOL HYDROCHLORIDEGeneric (ANDA)
ANDA 213305 · DEVA HOLDING AS
- 2024ISOPROTERENOL HYDROCHLORIDEGeneric (ANDA)
ANDA 217648 · GLAND
- 2024ISOPROTERENOL HYDROCHLORIDEGeneric (ANDA)
ANDA 211590 · SOMERSET THERAPS LLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
